Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NC410 plus pembrolizumab in advanced/metastatic solid tumors with various MSI statuses; terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]
Phase II, single-arm trial evaluating RAD001 (everolimus) with letrozole and metformin in advanced or recurrent endometrial carcinoma; resul…
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) [Phase 3]
Phase 3 trial evaluating pembrolizumab in combination with adjuvant chemotherapy with or without radiotherapy in newly diagnosed endometrial…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 trial evaluating onapristone plus anastrozole for refractory hormone receptor positive endometrial cancer completed with posted resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach [Phase 2]
Phase 2 trial results for the UPPROACH approach using upfront intensity-modulated proton beam therapy in endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) [Phase 3]
Phase 3 trial evaluating pembrolizumab with adjuvant chemotherapy, with or without radiotherapy, in newly diagnosed endometrial cancer after…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Results: Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation [Phase 2]
Phase 2 trial evaluating bevacizumab and/or niraparib in patients with recurrent endometrial or ovarian cancer harboring ARID1A mutation; st…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma [Phase 2]
Phase 2 study updating pembrolizumab with olaparib in endometrial carcinosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) [Phase 3]
A Phase 3 study compares sacituzumab Tirumotecan (MK-2870) in combination with pembrolizumab (MK-3475) versus pembrolizumab alone in endomet…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors [NA]
This completed clinical trial evaluated the effectiveness and implementation of an electronic health record tool to assess heart health amon…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is studying the combination of cabozantinib and dostarlimab for recurrent gynecologic carcinosarcoma, and recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: GEN1047 for Solid Tumors - First in Human (FIH) Trial [Phase 1, Phase 2]
Genmab's GEN1047 first-in-human Phase 1/2 trial in solid tumors has been terminated, with indications including breast cancer, endometrial c…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer [Phase 4]
Phase 4 trial evaluating risk evaluation and screening to tailor prevention and reduce the incidence of endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06 [Phase 2]
A phase II randomized trial comparing IMRT versus 3D pelvic radiotherapy planning for adjuvant treatment of endometrial cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors [Phase 1]
Context Therapeutics reports an ongoing Phase 1 study of CTIM-76 in platinum-resistant ovarian cancer and other advanced solid tumors, with …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer [Phase 2]
A Phase 2 trial evaluating chemotherapy versus observation for stage I–II intermediate or high-risk endometrial cancer. The study is current…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors [Phase 1]
Phase 1 update reporting safety, pharmacokinetics, and preliminary efficacy data for AI-061 in advanced solid tumors across multiple indicat…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1 Study of the Safety and Tolerability of CTX-10726 [Phase 1]
Phase 1 study update on the safety and tolerability of CTX-10726, currently recruiting across gastroesophageal cancer, hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 [Phase 2]
Update on a Phase 2 study of disitamab vedotin in HER2-expressing solid tumors, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Intrauterine Injection of Type III Collage in FST of EC/AEH [Phase 2]
Phase 2 clinical trial evaluating intrauterine injection of Type III collagen for endometrial cancer and atypical endometrial hyperplasia; c…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center is conducting a trial examining how estrogen, diet, and genetics relate to endometrial cancer; the st…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: GYNecologic Cancer-Related COGnitive Impairment [NA]
This clinical trial update indicates completion of a study on gynecologic cancer-related cognitive impairment. The study enrolled patients w…